Atlas Trials

Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Clinical trial NCT03208868 · RECRUITING

Trial details

NCT number
NCT03208868
Sponsor
The Cleveland Clinic
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Cirrhosis, Liver
Start date
2013-08-05
Primary completion
2026-12-31
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.